Epixis' Acquisition

Epixis was acquired by VBI Vaccines on September 19, 2011.

Epixis is a French biotechnology company developing its âeVLP❠platform technology for a new generation of Virus-Like Particle (VLP) vaccines. In September 2011, Epixis was acquired by VBI Vacci…

Articles about Epixis' Acquisition: